The Predictive Value of Depression in the Years After Heart Transplantation for Mortality During Long-Term Follow-Up
Bibliographic Data
| ID | 19307992 |
|---|---|
| Authors | Britta S Bürker (0000-0002-0544-5071, Oslo University Hospital, corresponding author), Lars Gullestad (0000-0002-5932-6641, Rigshospitalet), Einar Gude (Rigshospitalet), Odd E Havik (Rigshospitalet), Anne Relbo Authen (Rigshospitalet), Ingelin Grov, Arne K Andreassen (Rigshospitalet), Arnt E Fiane (0000-0002-5369-3934, Rigshospitalet), Ira R Haraldsen, Ira Haraldsen (0000-0002-6908-5423, Rigshospitalet), Mary Amanda Dew (0000-0002-4666-1870, Rigshospitalet), Stein Andersson (0000-0002-7556-7621, Rigshospitalet, corresponding author), Ulrik Fredrik Malt (0000-0002-9881-2511, Rigshospitalet) |
| Year | 2019 |
| Volume | 81 |
| Issue | 6 |
| Pages | 513-520 |
| Publication date | 2019-07-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Psychosomatic Medicine (JOURNAL) |
| Journal identifiers | ISSN: 0033-3174 • E-ISSN: 1534-7796 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/psy.0000000000000702 |
| PMID | 31033937 |
| OpenAlex | W2941436213 |
| Language | EN |
| Citations received | 3 |
| References cited | 27 |
OBJECTIVE: Current understanding of the prognostic impact of depression on mortality after heart transplantation (HTx) is limited. We examined whether depression after HTx is a predictor of mortality during extended follow-up. Subsequently, we explored whether different symptom dimensions of depression could be identified and whether they were differentially associated with mortality. METHODS: Survival analyses were performed in a sample of 141 HTx recipients assessed for depression, measured by self-report of depressive symptoms (Beck Depression Inventory - version 1A [BDI-1A]), at median 5.0 years after HTx, and followed thereafter for survival status for up to 18.6 years. We used uni- and multivariate Cox proportional hazard models to examine the association of clinically significant depression (BDI-1A total score ≥10), as well as the cognitive-affective and the somatic subscales of the BDI-1A (resulting from principal component analysis) with mortality. In the multivariate analyses, we adjusted for relevant sociodemographic and clinical variables. RESULTS: Clinically significant depression was a significant predictor of mortality (hazard ratio = 2.088; 95% confidence interval = 1.366-3.192; p = .001). Clinically significant depression also was an independent predictor of mortality in the multivariate analysis (hazard ratio = 1.982; 95% confidence interval = 1.220-3.217; p = .006). The somatic subscale, but not the cognitive-affective subscale, was significantly associated with increased mortality in univariate analyses, whereas neither of the two subscales was an independent predictor of mortality in the multivariate analysis. CONCLUSIONS: Depression measured by self-report after HTx is associated with increased mortality during extended follow-up. Clinical utility and predictive validity of specific depression components require further study
Anxiety · Beck Depression Inventory · Confidence interval · Depression (economics) · Hazard ratio · Multivariate analysis · Multivariate statistics · Proportional hazards model · Psychiatry · Univariate analysis · Cardiac Health and Mental Health · Internal Medicine · Medicine · Renal Transplantation Outcomes and Treatments · Transplantation: Methods and Outcomes
Body-mass index and all-cause mortality
Five-Year Risk of Cardiac Mortality in Relation to Initial Severity and One-Year Changes in Depression Symptoms After Myocardial Infarction
Psychometric properties of the Beck Depression Inventory
Residual Symptoms After Treatment for Depression in Patients With Coronary Heart Disease
Assessment and Treatment of Depression in Patients With Cardiovascular Disease
Major Depression and Long-Term Survival of Patients With Heart Failure
The Stanford Integrated Psychosocial Assessment for Transplantation
Cardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease
| Unique citing works | 3 |
|---|---|
| Citations per year | 0,5 |
| Citation span | 2020 - 2022 (3) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 3 |